RU2001118219A - Ингибитор ангиогенеза - Google Patents
Ингибитор ангиогенеза Download PDFInfo
- Publication number
- RU2001118219A RU2001118219A RU2001118219/14A RU2001118219A RU2001118219A RU 2001118219 A RU2001118219 A RU 2001118219A RU 2001118219/14 A RU2001118219/14 A RU 2001118219/14A RU 2001118219 A RU2001118219 A RU 2001118219A RU 2001118219 A RU2001118219 A RU 2001118219A
- Authority
- RU
- Russia
- Prior art keywords
- angiogenesis inhibitor
- animal
- angiogenesis
- arsenolite
- administering
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Claims (4)
1. Способ лечения связанных с ангиогенезом заболеваний, включающий введение животному, страдающему таким заболеванием, эффективного количества арсенолита (твердый As4O6).
2. Способ по п. 1, в котором животное представляет собой человека.
3. Способ лечения связанных с ангиогенезом заболеваний, включающий введение животному, страдающему таким заболеванием, композиции, содержащей эффективное количество арсенолита (твердый As4О6) и фармацевтически приемлемые добавки.
4. Способ по п. 3, в котором животное представляет собой человека.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR2000-36452 | 2000-06-29 | ||
| KR10-2000-0036452A KR100399657B1 (ko) | 2000-06-29 | 2000-06-29 | 혈관신생 억제제 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2001118219A true RU2001118219A (ru) | 2003-04-20 |
Family
ID=36458402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2001118219/14A RU2001118219A (ru) | 2000-06-29 | 2001-06-28 | Ингибитор ангиогенеза |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6703049B2 (ru) |
| EP (1) | EP1166789A3 (ru) |
| JP (1) | JP2002029976A (ru) |
| KR (1) | KR100399657B1 (ru) |
| CN (1) | CN1329891A (ru) |
| CA (1) | CA2342059A1 (ru) |
| RU (1) | RU2001118219A (ru) |
| TW (1) | TW518227B (ru) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100483195B1 (ko) * | 2002-08-12 | 2005-04-14 | 배일주 | 육산화사비소를 유효성분으로 함유하는 사상충증예방·치료용 약제학적 조성물 |
| KR101100786B1 (ko) * | 2008-12-16 | 2011-12-29 | (주)천지산 | 암에 대한 방사선 치료 증진용 조성물 |
| KR101119587B1 (ko) | 2011-03-10 | 2012-04-17 | 배일주 | 육산화사비소를 함유하는 용출률 및 안정성이 개선된 경구투여형 약제학적 제제 |
| CN105200534A (zh) * | 2015-10-23 | 2015-12-30 | 安徽理工大学 | 一种新型静电纺丝溶液的配比方法及其制备过程 |
| CN108066359A (zh) * | 2016-11-09 | 2018-05-25 | 凯马斯株式会社 | 包含六氧化四砷的用于抑制癌转移的药物组合物 |
| KR101755556B1 (ko) * | 2016-11-18 | 2017-07-07 | 주식회사 케마스 | 육산화사비소의 결정다형을 포함하는 뇌암 예방 또는 치료용 약학 조성물 및 이의 제조방법 |
| KR101834366B1 (ko) * | 2016-11-21 | 2018-03-05 | 주식회사 케마스 | 육산화사비소의 결정다형을 포함하는 유방암 예방 또는 치료용 약학 조성물 및 이의 제조방법 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1231922A (en) * | 1915-11-26 | 1917-07-03 | Western Electric Co | Telephone-exchange system. |
| JP2766669B2 (ja) * | 1989-06-06 | 1998-06-18 | 曙ブレーキ工業株式会社 | 車両の発進防止装置 |
| ID25622A (id) * | 1997-11-10 | 2000-10-19 | Sloan Kettering Inst Cancer | Proses untuk memproduksi formulasi arsenat trioksida dan metoda untuk mengobati kanker dengan menggunakan arsenat trioksida atau melarsoprol |
| KR100272835B1 (ko) * | 1998-05-08 | 2000-11-15 | 배일주 | 천연 화학물질 육산화사비소의 신규한 항종양 치료제로서의 용도 및 그 약학적 조성물 |
| FR2782010A1 (fr) * | 1998-08-06 | 2000-02-11 | Inst Vaisseaux Et Du Sang | Nouvelle utilisation d'un compose d'arsenic vis-a-vis de la leucemie megacaryocytaire ou plaquettaire |
| FR2786103A1 (fr) * | 1998-10-30 | 2000-05-26 | Assist Publ Hopitaux De Paris | Utilisation de trioxyde d'arsenic pour la preparation d'un medicament destine a traiter les affections neoplastiques du tissu hematopoietique chez un mammifere et nouvelle composition pharmaceutique |
-
2000
- 2000-06-29 KR KR10-2000-0036452A patent/KR100399657B1/ko active IP Right Grant
-
2001
- 2001-03-22 TW TW090106766A patent/TW518227B/zh not_active IP Right Cessation
- 2001-03-26 CA CA002342059A patent/CA2342059A1/en not_active Abandoned
- 2001-04-03 CN CN01110419A patent/CN1329891A/zh active Pending
- 2001-04-04 US US09/824,879 patent/US6703049B2/en not_active Expired - Lifetime
- 2001-04-04 EP EP01303190A patent/EP1166789A3/en not_active Withdrawn
- 2001-05-31 JP JP2001163710A patent/JP2002029976A/ja active Pending
- 2001-06-28 RU RU2001118219/14A patent/RU2001118219A/ru not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR100399657B1 (ko) | 2003-09-29 |
| EP1166789A2 (en) | 2002-01-02 |
| CA2342059A1 (en) | 2001-12-29 |
| KR20020002033A (ko) | 2002-01-09 |
| US20020001630A1 (en) | 2002-01-03 |
| US6703049B2 (en) | 2004-03-09 |
| TW518227B (en) | 2003-01-21 |
| JP2002029976A (ja) | 2002-01-29 |
| CN1329891A (zh) | 2002-01-09 |
| EP1166789A3 (en) | 2003-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1118651T1 (el) | Αζακυκλικες ενωσεις για χρηση στην θεραπευτικη αντιμετωπιση ασθενειων που σχετιζονται με τη σεροτονινη | |
| EA200801805A1 (ru) | Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения | |
| EA200300036A1 (ru) | Комбинации ингибиторов дипептидилпептидазы iv и других антидиабетических агентов для лечения сахарного диабета | |
| WO2004029031A3 (en) | Therapeutic piperazine compounds | |
| EA200101089A1 (ru) | Новый способ лечения | |
| WO2002053101A3 (en) | Method for treating fibrotic diseases or other indications | |
| HK1069339A1 (en) | Substituted diketopiperazines as oxytocin antagonists | |
| CY1109191T1 (el) | Μια νεα χρηση της δεφεριπρονης | |
| RU93055870A (ru) | Производные бифенила, способ их получения и фармацевтическая композиция для лечения гипертонии и сердечных заболеваний | |
| ATE451123T1 (de) | Vaginal verabreichbare zusammensetzung zur behandlung von uteriner dysrhythmie | |
| EA200200132A1 (ru) | СЕЛЕКТИВНЫЕ АНТАГОНИСТЫ РЕЦЕПТОРА iGluRДЛЯ ЛЕЧЕНИЯ МИГРЕНИ | |
| EE200200636A (et) | Dibensoasuleeni derivaadid, nende valmistamismeetodid ja kasutamine | |
| RU2001118219A (ru) | Ингибитор ангиогенеза | |
| SE0004101D0 (sv) | New use | |
| RU2001120358A (ru) | Применение ингибиторов натрий-водород-антипортера для получения лекарственного средства для ингибирования обусловленных возрастом дисфункций органов, обусловленных возрастом заболеваний и для продления жизни | |
| RU97120700A (ru) | Новое фармакологическое применение антагонистов a-ii рецептора | |
| EE9800315A (et) | Meetod südamepuudulikkuse käitlemiseks endoteliini antagonistide abil | |
| RU2003104017A (ru) | Ингибиторы тромбина, содержащие аминоизохинолиновую группу | |
| RU2003100517A (ru) | Новый интерферон для лечения рассеянного склероза | |
| EA200300430A1 (ru) | Новые фармацевтические композиции, содержащие эпинастин и псевдоэфедрин | |
| WO2002000611A8 (en) | Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists | |
| SE0100873D0 (sv) | Method of treatment | |
| EA200200846A1 (ru) | Соединения, полезные для лечения или предупреждения заболеваний, опосредуемых альфа-2в-адреноцептором | |
| RU2002112882A (ru) | Способ повышения резистентности сухостойных коров | |
| EA200000168A1 (ru) | Фармацевтическая композиция, снижающая продуцирование белка мср-1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20060220 |